These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


401 related items for PubMed ID: 29969630

  • 21. SNHG1 promotes MPP+-induced cytotoxicity by regulating PTEN/AKT/mTOR signaling pathway in SH-SY5Y cells via sponging miR-153-3p.
    Zhao J, Geng L, Chen Y, Wu C.
    Biol Res; 2020 Jan 06; 53(1):1. PubMed ID: 31907031
    [Abstract] [Full Text] [Related]

  • 22. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G, Ru Y, Wu K, Yan F, Wang Q, Wang J, Pan T, Zhang M, Han H, Li X, Zou L.
    Prostate; 2018 Feb 06; 78(3):166-177. PubMed ID: 29181846
    [Abstract] [Full Text] [Related]

  • 23. MiR-212-3p improves rat functional recovery and inhibits neurocyte apoptosis in spinal cord injury models via PTEN downregulation-mediated activation of AKT/mTOR pathway.
    Guan C, Luan L, Li J, Yang L.
    Brain Res; 2021 Oct 01; 1768():147576. PubMed ID: 34216580
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H, Huhe M, Lou J.
    Biomed Res Int; 2021 Oct 01; 2021():7590976. PubMed ID: 34307670
    [Abstract] [Full Text] [Related]

  • 25. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
    Li Y, Gu J, Lu H.
    Dig Dis Sci; 2017 Dec 01; 62(12):3426-3437. PubMed ID: 29098549
    [Abstract] [Full Text] [Related]

  • 26. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X, Fan Y, Du Z, Fan J, Hao Y, Wang J, Wu X, Luo C.
    Med Sci Monit; 2018 Jan 13; 24():254-263. PubMed ID: 29330357
    [Abstract] [Full Text] [Related]

  • 27. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
    Song BF, Xu LZ, Jiang K, Cheng F.
    Funct Integr Genomics; 2023 Mar 08; 23(2):80. PubMed ID: 36884182
    [Abstract] [Full Text] [Related]

  • 28. Tumor suppressor miR-361-3p inhibits prostate cancer progression through Gli1 and AKT/mTOR signaling pathway.
    Wang S, Huang X, Zhang G, Chen Z, Guan H, Zhou W.
    Cell Signal; 2024 Feb 08; 114():110998. PubMed ID: 38048859
    [Abstract] [Full Text] [Related]

  • 29. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H, Dar AA, Saini S, Colden M, Varahram S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, Hashimoto Y, Shiina M, Kulkarni P, Dasgupta P, Imai-Sumida M, Tabatabai ZL, Greene K, Deng G, Dahiya R, Majid S.
    Oncotarget; 2016 Oct 18; 7(42):68371-68384. PubMed ID: 27634912
    [Abstract] [Full Text] [Related]

  • 30. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N, Hosseinpourfeizi MA, Khojasteh SMB, Baradaran B, Safaralizadeh R.
    Life Sci; 2020 Oct 15; 259():118239. PubMed ID: 32784058
    [Abstract] [Full Text] [Related]

  • 31. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.
    Zhang F, Wu Z.
    Biochimie; 2017 Sep 15; 140():66-72. PubMed ID: 28624527
    [Abstract] [Full Text] [Related]

  • 32. miR-17-5p knockdown inhibits proliferation, autophagy and promotes apoptosis in thyroid cancer via targeting PTEN.
    Shi YP, Liu GL, Li S, Liu XL.
    Neoplasma; 2020 Mar 15; 67(2):249-258. PubMed ID: 31973533
    [Abstract] [Full Text] [Related]

  • 33. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway.
    Li D, Li P, Guo Z, Wang H, Pan W.
    Int J Mol Med; 2017 Mar 15; 39(3):757-763. PubMed ID: 28112362
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK.
    Oncotarget; 2015 Jun 20; 6(17):15035-49. PubMed ID: 25909227
    [Abstract] [Full Text] [Related]

  • 35. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
    Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z.
    Biomed Pharmacother; 2019 Jan 20; 109():1406-1410. PubMed ID: 30551391
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM, Liu XN, Li YX, Cao YQ, Silayiding A, Zhang RK, Wang JP.
    Kaohsiung J Med Sci; 2019 Nov 20; 35(11):659-671. PubMed ID: 31332950
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y, Wang LQ, Guo QY, Shi TL.
    Int J Clin Exp Pathol; 2015 Nov 20; 8(3):2461-72. PubMed ID: 26045752
    [Abstract] [Full Text] [Related]

  • 38. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.
    Zheng Y, Yang X, Wang C, Zhang S, Wang Z, Li M, Wang Y, Wang X, Yang X.
    Sci Rep; 2020 Feb 27; 10(1):3576. PubMed ID: 32107418
    [Abstract] [Full Text] [Related]

  • 39. MiR-203a-3p targets PTEN to promote hepatocyte proliferation by regulating PI3K/Akt pathway in BRL-3A cells.
    Zhang Y, Zheng Y, Zhu G.
    Biosci Biotechnol Biochem; 2020 Apr 27; 84(4):725-733. PubMed ID: 31814541
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-92a-3p enhances functional recovery and suppresses apoptosis after spinal cord injury via targeting phosphatase and tensin homolog.
    He S, Wang Z, Li Y, Dong J, Xiang D, Ren L, Guo L, Shu J.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32297644
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.